Testicular Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032


 Testicular cancer, which primarily affects men between the ages of 15 and 45, is the most prevalent form of malignancy within this age group. When promptly identified and treated using a multimodal approach, it represents one of the most frequently curable types of cancer. Testicular cancer comprises approximately 1% of male tumors and 5% of urological malignancies. Epidemiological risk factors include cryptorchidism (undescended testicles), impaired spermatogenesis leading to sub- or infertility, disorders of sexual development, a family history of testicular tumors among first-degree relatives, and the presence of a contralateral tumor or germ-cell neoplasia in-situ (GCNIS). Genetic alterations have been identified as significant risk factors in the etiology of testicular cancer. The presence of the isochromosome of the short arm of chromosome 12 (i12p) is a characteristic feature of all types of adult germ cell tumors (GCTs) and GCNIS. Approximately 66% of GCNIS cases exhibit abnormalities in the p53 gene. Moreover, genetic polymorphisms in the PTEN tumor suppressor gene have been associated with an increased risk of testicular cancer. Dysregulation of the pluripotent program of fetal germ cells, indicated by markers M2A, C-KIT, and OCT4/NANOG, is believed to contribute to developing GCNIS and germ cell neoplasia. The most common presentation of testicular cancer is a painless mass, although up to 45% of patients may experience testicular pain, with 25% exhibiting signs and symptoms resembling acute epididymitis. Symptoms indicative of metastatic disease, such as back pain, dyspnea, and gynecomastia resulting from the production of HCG by malignant tumors, are less frequently observed. Complications associated with testicular malignancy can be broadly categorized into two groups: those stemming from the disease and those arising from its treatment. Disease-related complications encompass chronic fatigue, anxiety disorders, metastatic complications, and venous thromboembolism. Treatment-related complications include hypogonadism, which can lead to depression, sexual dysfunction, reduced physical well-being, peripheral neuropathy (associated with cisplatin use), and hearing loss (associated with cisplatin use). The average age at initial diagnosis of testicular cancer is approximately 33 years. While the disease predominantly affects young and middle-aged men, around 6% of cases occur in children and teenagers, and approximately 8% occur in men over 55.

·       The annual incidence of testicular cancer in the United States is 5.6 cases per 1 million population.

Thelansis’s “Testicular Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Testicular Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Testicular Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Testicular Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Testicular Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Metabolic Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Metabolic syndrome refers to a clustering of multiple disorders that collectively increase an individual's susceptibility to atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, as well as vascular and neurological complications such as cerebrovascular accidents. The underlying causes of metabolic syndrome typically include excess weight, obesity, a sedentary lifestyle, and genetic predisposition. This syndrome exerts detrimental effects on various body systems. Insulin resistance, a key component of metabolic syndrome, leads to microvascular damage, increasing the risk of endothelial dysfunction, vascular resistance, hypertension, and inflammation of vessel walls. Bariatric surgery is recognized as the most effective standalone therapy for metabolic syndrome. However, patients undergoing this procedure require long-term follow-up to mitigate potential surgical, nutritional, and psychiatric complications. Thelansis’s “Metabolic Syndrome Market Outl...
Read more

Type 1 Diabetes Mellitus (T1D) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Type 1 Diabetes Mellitus (T1D) is characterized as an autoimmune disorder resulting in the autoimmune destruction of insulin-producing pancreatic beta cells. This condition necessitates life-long insulin replacement, administered through multiple daily insulin injections, insulin pump therapy, or an automated insulin delivery system. The absence of insulin can lead to the development of Diabetic Ketoacidosis (DKA), a life-threatening condition. The most common symptoms associated with this disease are polyuria and polydipsia. Effective management of T1D involves: Multiple daily insulin injections Insulin pump therapy An automated insulin delivery system in conjunction with glucose monitoring Continuous Glucose Monitoring (CGM) is the preferred method. However, all individuals with T1D should be capable of performing Blood Glucose Monitoring (BGM) via capillary blood if CGM is not available. Acute complications of diabetes primarily include hypo...
Read more